Cryopreserved CD34 + Cell Dose, but Not Total Nucleated Cell Dose, Influences Hematopoietic Recovery and Extensive Chronic Graft-versus-Host Disease after Single-Unit Cord Blood Transplantation in Adult Patients-Reference-Cited by-同舟云学术

Cryopreserved CD34 + Cell Dose, but Not Total Nucleated Cell Dose, Influences Hematopoietic Recovery and Extensive Chronic Graft-versus-Host Disease after Single-Unit Cord Blood Transplantation in Adult Patients

Published:2017-07 Issue:7 Volume:23 Page:1142-1150
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Konuma Takaaki^ORCID,Kato Seiko,Oiwa-Monna Maki,Tanoue Susumu,Ogawa Miho,Isobe Masamichi,Tojo Arinobu,Takahashi Satoshi

Funder

Japanese Foundation for Promotion of Cancer Research

Japanese Foundation for Multidisciplinary Treatment of Cancer

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference57 articles.

1. Cord-blood transplantation in patients with minimal residual disease;Milano;N Engl J Med,2016

2. Comparison of outcomes of 8/8 and 7/8 allele-matched unrelated bone marrow transplantation and single-unit cord blood transplantation in adults with acute leukemia;Terakura;Biol Blood Marrow Transplant,2016

3. Single-institute comparative analysis of unrelated bone marrow transplantation and cord blood transplantation for adult patients with hematologic malignancies;Takahashi;Blood,2004

4. Comparison of transplant outcomes from matched sibling bone marrow or peripheral blood stem cell and unrelated cord blood in patients 50 years or older;Konuma;Am J Hematol,2016

5. Outcomes among 562 recipients of placental-blood transplants from unrelated donors;Rubinstein;N Engl J Med,1998

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Levels of C-reactive protein and body temperature elevation during neutropenia predict engraftment and non-relapse mortality for unrelated single-unit cord blood transplantation in adults;Transplantation and Cellular Therapy;2024-09

2. Allogeneic hematopoietic cell transplantation from alternative donors in acute myeloid leukemia;Annals of Hematology;2024-08-17

3. A higher CD34 + cell dose correlates with better event-free survival after KIR-ligand mismatched cord blood transplantation for childhood acute myeloid leukemia;Journal of Hematology & Oncology;2024-04-29

4. Effects of CD34⁺ cell dose on engraftment and long‐term outcomes after allogeneic bone marrow transplantation;Clinical Transplantation;2024-04

5. Development of an umbilical cord blood transplantation–specific nonrelapse mortality risk assessment score;Blood Advances;2024-03-13